Lineage Cell Therapeutics, Inc. (LCTX) Ownership

$1.75

$0.07 (3.87%)
Last update: 04:00 PM EST
Day's range
$1.62
Day's range
$1.75

Lineage Cell Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BROADWOOD CAPITAL INC 11/14/2025 49.56 M $83.76 M   0.00% 21.70%
VANGUARD GROUP INC 11/07/2025 9.01 M $15.22 M   6.18% 3.94%
RAFFLES ASSOCIATES LP 11/14/2025 5.39 M $9.11 M   -0.08% 2.36%
COMERICA BANK 11/14/2025 4.60 M $7.77 M   0.00% 2.01%
MILLENNIUM MANAGEMENT LLC 11/14/2025 2.68 M $4.53 M   3.05% 1.17%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 2.42 M $4.09 M   -0.49% 1.06%
BLACKROCK, INC. 11/12/2025 2.23 M $3.77 M   -1.33% 0.98%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 1.91 M $3.22 M   -3.38% 0.83%
DAUNTLESS INVESTMENT GROUP, LLC 11/14/2025 1.61 M $2.73 M   33.85% 0.71%
MORGAN STANLEY 11/14/2025 1.01 M $1.70 M   20.18% 0.44%
STATE STREET CORP 11/14/2025 955.62 K $1.62 M   12.49% 0.42%
GSA CAPITAL PARTNERS LLP 11/07/2025 670.86 K $1.13 M   -25.26% 0.29%
RED CRANE WEALTH MANAGEMENT, LLC 10/29/2025 511.36 K $864.20 K   3.10% 0.22%
NORTHERN TRUST CORP 11/14/2025 443.35 K $749.26 K   -13.15% 0.19%
EAM INVESTORS, LLC 11/14/2025 442.22 K $747.35 K   100.00% 0.19%
TWO SIGMA INVESTMENTS, LP 11/14/2025 354.35 K $598.85 K   11.44% 0.16%
ROYAL BANK OF CANADA 11/14/2025 306.27 K $517.00 K   17.82% 0.13%
BANK OF AMERICA CORP /DE/ 11/14/2025 233.44 K $394.51 K   125.95% 0.10%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 221.00 K $373.49 K   47.33% 0.10%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 218.27 K $368.88 K   219.70% 0.10%
UBS GROUP AG 11/13/2025 208.08 K $351.66 K   -8.58% 0.09%
FMR LLC 11/13/2025 194.03 K $327.91 K   -0.44% 0.09%
CITADEL ADVISORS LLC 11/14/2025 193.97 K $327.81 K   4.58% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 185.00 K $312.65 K   -66.19% 0.08%
QUADRATURE CAPITAL LTD 11/13/2025 179.03 K $304.35 K   100.00% 0.08%
IEQ CAPITAL, LLC 11/14/2025 160.41 K $271.10 K   596.24% 0.07%
JANE STREET GROUP, LLC 11/14/2025 144.86 K $244.82 K   -90.38% 0.06%
GOLDMAN SACHS GROUP INC 11/14/2025 144.68 K $244.50 K   -19.71% 0.06%
CITADEL ADVISORS LLC 11/14/2025 118.00 K $199.42 K   -49.87% 0.05%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 109.30 K $184.72 K   60.03% 0.05%
WILLIAMS JONES WEALTH MANAGEMENT, LLC. 11/14/2025 101.30 K $171.20 K   0.00% 0.04%
COMMONWEALTH EQUITY SERVICES, LLC 10/22/2025 100.92 K $171.00 K   64.04% 0.04%
HIGHTOWER ADVISORS, LLC 11/07/2025 98.37 K $166.25 K   70.47% 0.04%
RAYMOND JAMES FINANCIAL INC 11/14/2025 90.38 K $152.74 K   30.27% 0.04%
ADVISOR GROUP HOLDINGS, INC. 11/14/2025 84.80 K $122.93 K   4.07% 0.04%
SUMMITTX CAPITAL, L.P. 11/14/2025 73.84 K $124.78 K   -74.23% 0.03%
CATALYST FUNDS MANAGEMENT PTY LTD 11/12/2025 62.40 K $105.46 K   -24.91% 0.03%
JEFFERIES FINANCIAL GROUP INC. 11/13/2025 62.20 K $105.12 K   100.00% 0.03%
FORT SHERIDAN ADVISORS LLC 11/13/2025 55.18 K $93.25 K   0.00% 0.02%
CIBC WORLD MARKET INC. 11/06/2025 47.05 K $79.52 K   0.00% 0.02%
POINT72 ASIA (SINGAPORE) PTE. LTD. 11/14/2025 46.82 K $79.12 K   -57.91% 0.02%
BEIRNE WEALTH CONSULTING SERVICES, LLC 11/07/2025 45.00 K $76.05 K   0.00% 0.02%
CUBIST SYSTEMATIC STRATEGIES, LLC 11/14/2025 37.49 K $63.35 K   -91.39% 0.02%
ORG PARTNERS LLC 10/24/2025 35.70 K $60.33 K   -39.70% 0.02%
RATHBONES GROUP PLC 11/13/2025 35.00 K $59.15 K   0.00% 0.02%
NWAM LLC 10/28/2025 35.00 K $56.35 K   133.33% 0.02%
TRUST CO OF TOLEDO NA /OH/ 10/16/2025 33.80 K $57.11 K   0.00% 0.01%
BANK OF NEW YORK MELLON CORP 11/03/2025 31.13 K $52.62 K   74.96% 0.01%
EQUITABLE HOLDINGS, INC. 11/14/2025 30.02 K $50.74 K   100.00% 0.01%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 29.10 K $49.18 K   100.00% 0.01%

Lineage Cell Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 170 institutional investors and hedge funds held shares of Lineage Cell Therapeutics, Inc.. The most heavily invested institutionals were:

BROADWOOD CAPITAL INC: 49.56 M

VANGUARD GROUP INC: 9.01 M

RAFFLES ASSOCIATES LP: 5.39 M

COMERICA BANK: 4.6 M

MILLENNIUM MANAGEMENT LLC: 2.68 M

GEODE CAPITAL MANAGEMENT, LLC: 2.42 M

38.50% of Lineage Cell Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 98.49 M shares in the last 24 months. This purchase volume represents approximately $171.86 M in transactions.